|
Sep 2026
As of Sep 30, 2026
|
|
|---|---|
| ASSETS | |
| Cash and cash equivalents | |
| Interest-earning deposits in other financial institutions | |
| Investment securities available for sale, at fair value, net of allowance of credit losses of $0 at September 30, 2026 and December 31, 2025 (amortized cost of $395,366 and $390,996 at September 30, 2026 and December 31, 2025) | |
| Investment securities held to maturity, at amortized cost, net of allowance for credit losses of $0 at September 30, 2026 and December 31, 2025 (fair value of $5,612 and $6,257 at September 30, 2026 and December 31, 2025) | |
| Loans held for investment | |
| Allowance for credit losses on loans | |
| Loans held for investment, net of allowance | |
| Non-marketable equity investments, at cost | |
| Premises and equipment, net | |
| Goodwill | |
| Core deposit intangible asset, net | |
| Bank-owned life insurance | |
| Accrued interest receivable and other assets | |
| Total assets | |
| LIABILITIES AND SHAREHOLDERS’ EQUITY | |
| Liabilities | |
| Deposits | |
| Noninterest-bearing | |
| Interest-bearing | |
| Total deposits | |
| Subordinated debentures | |
| Accrued interest payable and other liabilities | |
| Total liabilities | |
| Shareholders’ equity | |
| Preferred stock, no par value; 10,000,000 shares authorized; no shares issued or outstanding | |
| Common stock, no par value; 30,000,000 shares authorized; 10,524,552 and 10,482,767 shares issued at September 30, 2026 and December 31, 2025, respectively | |
| Retained earnings | |
| Accumulated other comprehensive loss | |
| Total shareholders’ equity | |
| Total liabilities and shareholders’ equity |
Loading...